CLINICAL TRIALS PROFILE FOR FALLBACK SOLO
✉ Email this page to a colleague
All Clinical Trials for FALLBACK SOLO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00664677 ↗ | Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia | Terminated | Erimos Pharmaceuticals | Phase 1 | 2007-08-01 | This study is designed to determine the safety, maximum tolerated dose,dose limiting toxicity of Terameprocol(EM-1421)and determine the pharmacokinetics (clearance from the blood)of Terameprocol(EM-1421)given as intravenous infusion three times a week in patients with leukemia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FALLBACK SOLO
Condition Name
Clinical Trial Locations for FALLBACK SOLO
Trials by Country
Clinical Trial Progress for FALLBACK SOLO
Clinical Trial Phase
Clinical Trial Sponsors for FALLBACK SOLO
Sponsor Name